Evidence map›Paper›PMID 37649135›Full record

ArticleFEBS open bio2023

Biochemical characterisation of a novel broad pH spectrum subtilisin from Fictibacillus arsenicus DSM 15822

Fabian Falkenberg, Sophie Kohn, Michael Bott, Johannes Bongaerts, Petra Siegert

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in FEBS open bio, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Fabian FalkenbergInstitute of Nano- and Biotechnologies, Aachen University of Applied Sciences, Jülich, Germany.ORCID 0000-0003-2374-0418
Sophie KohnInstitute of Nano- and Biotechnologies, Aachen University of Applied Sciences, Jülich, Germany.
Michael BottInstitute of Bio- and Geosciences, IBG-1: Biotechnology, Forschungszentrum Jülich, Germany.ORCID 0000-0002-4701-8254
Johannes BongaertsInstitute of Nano- and Biotechnologies, Aachen University of Applied Sciences, Jülich, Germany.ORCID 0009-0007-8656-1472
Petra SiegertInstitute of Nano- and Biotechnologies, Aachen University of Applied Sciences, Jülich, Germany.ORCID 0000-0001-7172-3060

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Subtilisins from microbial sources, especially from the Bacillaceae family, are of particular interest for biotechnological applications and serve the currently growing enzyme market as efficient and novel biocatalysts. Biotechnological applications include use in detergents, cosmetics, leather processing, wastewater treatment and pharmaceuticals. To identify a possible candidate for the enzyme market, here we cloned the gene of the subtilisin SPFA from Fictibacillus arsenicus DSM 15822

Indexed as

BacillaceaeSubtilisinHydrogen-Ion ConcentrationPhylogenySodium ChlorideSodium ChlorideSubtilisinBacillaceaebiotechnological applicationbroad pH spectrumsubtilasessubtilisin

Identifiers

PMID37649135
PMCPMC10626276

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.